Zobrazeno 241 - 250
of 322
pro vyhledávání: '"Marco Ladetto"'
Autor:
Marco Ladetto, Mathias Witzens, Robert H. Vonderheide, Joachim L. Schultze, Andreas Trojan, John G. Gribben, John W. Donovan
Although the idiotypic structures of immunoglobulin from malignant B cells were the first tumor-specific determinants recognized, and clinical vaccination trials have demonstrated induction of tumor-specific immunity, the function of immunoglobulin-s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e99b3d415589d5973cdc748154cdf9e9
http://hdl.handle.net/2318/40440
http://hdl.handle.net/2318/40440
Autor:
Andreas Trojan, John W. Donovan, Christina Poor, Sabine Harig, Edie Weller, Robert L. Schlossman, Marco Ladetto, Kenneth C. Anderson, John G. Gribben
The majority of patients with multiple myeloma (MM) have persistence of minimal residual disease (MRD), as determined by polymerase chain reaction (PCR) detection of clonal immunoglobulin H (IgH) gene rearrangements. As a result, PCR analysis has not
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f50b54246e84a028b3ae74738c99d52f
http://hdl.handle.net/2318/40678
http://hdl.handle.net/2318/40678
Autor:
Gullu Gorgun, Samantha Pozzi, Loredana Santo, Mario Boccadoro, Noopur Raje, T Cirstea, NC Munshi, Hiroshi Ikeda, Nileshwari Vaghela, Teru Hideshima, KC Anderson, Marco Ladetto, Sonia Vallet, Yutaka Okawa, Squires
Publikováno v:
Clinical Lymphoma and Myeloma. 9:S137-S138
Autor:
Silvia Campana, Alessandro Pileri, Marco Ladetto, Paolo Corradini, Mario Boccadoro, Monica Astolfi
Publikováno v:
Molecular Biology of Hematopoiesis 5 ISBN: 9781461380313
Molecular pathogenesis of multiple myeloma (MM) is largely unknown. There are several lines of evidence suggesting that malignant transformation occurs through a multistep process involving the activation of proto-oncogenes, the loss of tumor suppres
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::10ef32f6dba5f547cc0d02823520cb9d
https://doi.org/10.1007/978-1-4613-0391-6_22
https://doi.org/10.1007/978-1-4613-0391-6_22
Autor:
Pellegrino Musto, Luigi Rigacci, Renato Fanin, Giorgina Specchia, Chiara Lobetti-Bodoni, Giuseppe Rossi, Enrica Gamba, Elisa Genuardi, Giovannino Ciccone, Guido Parvis, Francesco Di Raimondo, Antonello Pinto, Alessandro Pulsoni, Mario Petrini, Andrea Evangelista, Delia Rota-Scalabrini, Barbara Botto, Barbara Olivero, Barbara Mantoan, Carola Boccomini, Marco Ladetto, Luca Baldini, Luigi Gugliotta, Umberto Vitolo, Andrea Gallamini, Stefano Sacchi
Publikováno v:
Blood. 120:787-787
Abstract 787 Background: Many studies support the value of PCR-based MRD detection using the bcl-2-IgH translocation as an outcome predictor in FL but some failed to confirm this observation. Concerns have been raised particularly for programs which
Autor:
Mario Uhr, Francesco Forconi, Emanuele Zucca, Georg Stussi, Andrea Rinaldi, Francesco Bertoni, Michael Mian, Franco Cavalli, Ivo Kwee, Roberto Marasca, Gianluca Gaidano, Afua Adjeiwaa Mensah, Davide Rossi, Marco Ladetto
Publikováno v:
Blood. 120:3906-3906
Abstract 3906 The clinical course of CLL patients ranges from an indolent and chronic disease to a rapidly progressing leukemia or lymphoma necessitating aggressive treatment. Very recent data have shown that genomic complexity evaluated by conventio
Autor:
Anna Maria Barbui, Federica Delaini, Cristina Boschini, Marco Ladetto, Daniele Caracciolo, Angela Gueli, Alessandro M. Gianni, Alessandro Rambaldi, Andrea Rossi, Elena Oldani, Corrado Tarella, Liliana Devizzi, Giuseppe Gritti, Roberto Passera, Alberto De Crescenzo
Publikováno v:
Blood. 120:1553-1553
Abstract 1553 Background and Aim The number and type of lymphocytes and monocytes/macrophages detectable in the peripheral blood and the lymph nodes of patients with Hodgkin and non-Hodgkin lymphomas has been recently extensively investigated and int
Autor:
Paola Omedè, Moreno Festuccia, Roberto Passera, Nicola Mordini, Renato Fanin, Sara Barbiero, Silvia Cena, Simone Ferrero, Benedetto Bruno, Luisa Giaccone, Francesca Patriarca, Daniela Barbero, Luigia Monitillo, Antonio Palumbo, Alberto Rocci, Marco Ladetto, Andrea Gallamini, Mario Boccadoro, Daniela Drandi
Publikováno v:
Blood. 120:4204-4204
Abstract 4204 Background and aims. Myeloablative allografting induces high rates of persistent molecular remissions (MR) in multiple myeloma (MM) [Corradini et al, J Clin Oncol 1999] and greatly reduces the risk of relapse. Similar results have also
Autor:
Malek Faham, Francois Pepin, Daniela Drandi, Marco Ladetto, Victoria Carlton, Mario Boccadoro, Antonio Palumbo, Luigia Monitillo, Roberto Passera, Monika Brüggemann, Christiane Pott, Simone Ferrero, Heiko Trautmann
Publikováno v:
Blood. 120:788-788
Abstract 788 Background. Real-Time Quantitative (RQ) PCR-based MRD detection using tumor-specific primers derived from the immunoglobulin heavy chain variable region (IGH) is an established disease monitoring tool with high predictive value in ALL, M
Autor:
Giovanni Pizzolo, Pietro Leoni, Atto Billio, Alessandro Massimo Gianni, Arianna Masciulli, Marco Scarano, Valerio Zoli, Antonino Mulè, Maurizio Frezzato, Tiziano Barbui, Anna Maria Barbui, Leonardo Flenghi, Paolo Corradini, Manuela Zanni, Alessandro Rambaldi, Giorgio La Nasa, Sergio Cortelazzo, Roberto Marchioli, Andrea Rossi, Francesco Di Raimondo, Corrado Tarella, Caterina Patti, Andrés J.M. Ferreri, Andrea Gallamini, G. Semenzato, Massimo Di Nicola, Marco Ladetto
Publikováno v:
Blood. 120:746-746
Abstract 746 Background The clinical benefit of high dose chemotherapy programs in patients with diffuse large B cell lymphomas (DLBCL) with unfavorable presentation (IPI>2) is still matter of debate and several prospective randomized clinical trials